Skip to content
value.today

Avantis Medical Systems Inc

Total raised
$46 M
11 rounds on record
Latest round
$2 M
Feb 2018
First round on record
Dec 2009
Today
Private
No later event on record

Funding rounds

11 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Avantis Medical Systems Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2018$2 MNo. 11$2 to $10 million

Avantis Medical Systems Inc: Raise no. 11, Feb 2018

Investors in this round

4 investors had bought by the notice of Mar 19, 2018: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Anthony DiTonno · Executive Officer, Director
  • Daniel Turner III · Director
  • David Silverman · Director
  • Michael Mayer · Director
  • Phil English · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 19, 2018. Read the notice at the SEC.

debt, optionsSEC
Aug 2016$2 MNo. 10$2 to $10 million

Avantis Medical Systems Inc: Raise no. 10, Aug 2016

Investors in this round

1 investor had bought by the notice of Aug 17, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Anthony DiTonno · Executive Officer, Director
  • Camran Nezhat · Director
  • Daniel Turner III · Director
  • David Silverman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 17, 2016. Read the notice at the SEC.

debt, optionsSEC
Mar 2016$2 MNo. 9Under $2 million

Avantis Medical Systems Inc: Raise no. 9, Mar 2016

Investors in this round

8 investors had bought by the notice of Aug 17, 2016: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Anthony DiTonno · Executive Officer, Director
  • Camran Nezhat · Director
  • Daniel Turner III · Director
  • David Silverman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 17, 2016. Read the notice at the SEC.

debt, optionsSEC
Sep 2015$2 MNo. 8$2 to $10 million

Avantis Medical Systems Inc: Raise no. 8, Sep 2015

Investors in this round

1 investor had bought by the notice of Aug 17, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Anthony DiTonno · Executive Officer, Director
  • Camran Nezhat · Director
  • Daniel Turner III · Director
  • David Silverman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 17, 2016. Read the notice at the SEC.

debt, optionsSEC
Jun 2015$1 MNo. 7Under $2 million

Avantis Medical Systems Inc: Raise no. 7, Jun 2015

Investors in this round

19 investors had bought by the notice of Aug 17, 2016: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Anthony DiTonno · Executive Officer, Director
  • Camran Nezhat · Director
  • Daniel Turner III · Director
  • David Silverman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 17, 2016. Read the notice at the SEC.

debt, optionsSEC
Feb 2013$10 MNo. 6$10 to $50 million

Avantis Medical Systems Inc: Raise no. 6, Feb 2013

Investors in this round

23 investors had bought by the notice of Aug 17, 2016: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $17 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Anthony DiTonno · Executive Officer, Director
  • Camran Nezhat · Director
  • Daniel Turner III · Director
  • David Silverman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D and 4 amendments, newest notice filed Aug 17, 2016. Read the notice at the SEC.

debt, optionsSEC
Jun 2011$18 MNo. 5$10 to $50 million

Avantis Medical Systems Inc: Raise no. 5, Jun 2011

Investors in this round

40 investors had bought by the notice of Jul 8, 2011: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $35 M offered; $17 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • John Reed · Executive Officer
  • Matthew J. Jenusaitis · Executive Officer, Director
  • Richard Randall · Executive Officer, Director
  • Camran J. Nezhat · Director
  • Howard J. Palefsky · Director
  • John J. Savarese · Director
  • Thomas J. Fogarty · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Funds to be used for working capital.”

Signed by John Reed, Coo. Source: SEC Form D, newest notice filed Jul 8, 2011. Read the notice at the SEC.

equity, optionsSEC
Apr 2011$2 MNo. 4$2 to $10 million

Avantis Medical Systems Inc: Raise no. 4, Apr 2011

Investors in this round

9 investors had bought by the notice of May 12, 2011: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • John Reed · Executive Officer
  • Matthew J. Jenusaitis · Executive Officer, Director
  • Richard Randall · Executive Officer, Director
  • Camran J. Nezhat · Director
  • Howard J. Palefsky · Director
  • Thomas J. Fogarty · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Funds to be used for working capital”

Signed by Michael O'Donnell, Secretary. Source: SEC Form D, newest notice filed May 12, 2011. Read the notice at the SEC.

debt, optionsSEC
Nov 2010$2 MNo. 3$2 to $10 million

Avantis Medical Systems Inc: Raise no. 3, Nov 2010

Investors in this round

7 investors had bought by the notice of Feb 15, 2011: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $2 M still to sell
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • John Reed · Executive Officer
  • Matthew Jenusaitis · Executive Officer, Director
  • Camran Neshat · Director
  • Howard Palefsky · Director
  • Thomas Fogarty · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Funds to be used for working capital.”

Signed by Ann Coppel, Sr. Legal Assistant. Source: SEC Form D and 1 amendment, newest notice filed Feb 15, 2011. Read the notice at the SEC.

debt, optionsSEC
Jun 2010$3 MNo. 2$2 to $10 million

Avantis Medical Systems Inc: Raise no. 2, Jun 2010

Investors in this round

21 investors had bought by the notice of Aug 26, 2010: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • John Reed · Executive Officer
  • Matthew Jenusaitis · Executive Officer, Director
  • Camran Nezhat · Director
  • Howard Palefsky · Director
  • Thomas Fogarty · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Funds to be used for working capital.”

Signed by Ann Coppel, Sr. Legal Assistant. Source: SEC Form D and 1 amendment, newest notice filed Aug 26, 2010. Read the notice at the SEC.

debt, optionsSEC
Dec 2009$1 MNo. 1Under $2 million

Avantis Medical Systems Inc: Raise no. 1, Dec 2009

Investors in this round

2 investors had bought by the notice of Dec 17, 2009: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $4 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Matthew J. Jenusaitis · Executive Officer, Director
  • Scott Dodson · Executive Officer, Director
  • Camran J. Nazhat · Director
  • Fred R. Seddiqui · Director
  • Howard J. Palefsky · Director
  • Thomas J. Fogarty · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Funds to be used for working capital.”

Signed by Ann Coppel, Sr. Legal Assistant. Source: SEC Form D, newest notice filed Dec 17, 2009. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Avantis Medical Systems Inc chose not to state its revenue in its newest notice of a funding round (Mar 2018).

    SEC Form D · Mar 2018

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Mar 2018

That is all the official record says: Avantis Medical Systems Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Avantis Medical Systems Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 11 rounds above had up to 40 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Avantis Medical Systems Inc
NameRoleNamed in
Anthony DiTonnoExecutive officerMar 2018
John ReedExecutive officerJul 2011
Matthew J. JenusaitisExecutive officerJul 2011
Richard RandallExecutive officerJul 2011
Matthew JenusaitisExecutive officerFeb 2011
Mark TenBoerExecutive officerNov 2010
Scott DodsonExecutive officerJun 2010
Anthony DiTonnoDirectorMar 2018
Daniel Turner IIIDirectorMar 2018
David SilvermanDirectorMar 2018
Michael MayerDirectorMar 2018
Phil EnglishDirectorMar 2018
Camran NezhatDirectorAug 2016
Camran J. NezhatDirectorJan 2014
Howard J. PalefskyDirectorJan 2014
John J. SavareseDirectorJan 2014
Thomas J. FogartyDirectorJan 2014
Matthew J. JenusaitisDirectorJul 2013
Richard RandallDirectorJul 2011
Camran NeshatDirectorFeb 2011
Howard PalefskyDirectorFeb 2011
Matthew JenusaitisDirectorFeb 2011
Thomas FogartyDirectorFeb 2011
Fred R. SeddiquiDirectorJun 2010
Scott DodsonDirectorJun 2010
Camran J. NazhatDirectorDec 2009